| Literature DB >> 34501582 |
Antonio J Diaz1, Ignacio Rosety2, Francisco J Ordonez3, Francisco Brenes4, Natalia Garcia-Gomez2, Cristina Castejon-Riber5, Manuel Rosety-Rodriguez3, Marco Bernardi6, Jose Ramon Alvero-Cruz7, Miguel A Rosety8.
Abstract
Recent studies have emphasized that regular exercise should be encouraged as a key part of care and support for people with Down syndrome (DS). However, muscle hypotonia has traditionally been considered a major barrier to resistance training (RT) in people with DS. The main objective of this study was to analyze the impact of circuit RT on markers of muscle damage. The secondary objective was to assess the influence of a RT program on body composition and work task performance. Thirty-six men with DS were recruited and randomly assigned to perform a circuit RT program with six stations 3 days/week for 12 weeks (n = 18) or to a control group (n = 18). Body composition was assessed by bioelectrical impedance analysis. Serum markers of muscle damage (creatine kinase, myoglobin, and lactate dehydrogenase) were determined at baseline and at the end of training weeks 1, 6, and 12. Work task performance was assessed using the weighted pail-carry test. RT did not induce significant changes in markers of muscle damage during the intervention. Furthermore, muscle mass and work task performance were significantly improved in the exercise group. These findings suggest that circuit RT can be used safely to increase muscle mass and work task performance in young adults with DS. Muscle hypotonia should not be considered a major barrier to exercise in people with DS, provided that qualified staff design and supervise all training sessions.Entities:
Keywords: Down syndrome; body composition; creatine kinase; muscle damage; resistance training
Mesh:
Substances:
Year: 2021 PMID: 34501582 PMCID: PMC8431092 DOI: 10.3390/ijerph18178996
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Characteristics of the 12-week circuit resistance training programme, comprised of 6 stations, performed by participants in the intervention group.
| Protocol | 1st–2nd-wk | 3rd–4th-wk | 5th–6th-wk | 7th–8th-wk | 9th–10th-wk | 11th–12th-wk |
|---|---|---|---|---|---|---|
| Load | 40% | 45% | 50% | 55% | 60% | 65% |
| Sets | 2 | 2 | 2 | 2 | 2 | 2 |
| Rep | 10 | 10 | 8 | 8 | 6 | 6 |
| Rest | 90 | 90 | 90 | 90 | 90 | 90 |
Note: wk: Week. Load: expressed as percentage of 8 repetition-maximum (8RM) test. Rep: Number of repetitions. Rest: Resting periods between stations expressed in seconds.
Influence of the circuit resistance training programme on body composition in adults with Down syndrome at baseline and after completing the intervention programme.
| Characteristics | Study Group | Control Group | ||
|---|---|---|---|---|
| Pre-Test | Post-Test | Baseline | Final | |
| Age (years) | 28.4 (3.6) | 28.4 (3.6) | 27.8 (3.0) | 27.8 (3.0) |
| Weight (kg) | 71.1 (8.2) | 72.1 (9.1) | 69.8 (8.5) | 70.2 (8.7) |
| BMI (kg/m2) | 31.4 (5.7) | 31.6 (6.0) | 30.8 (5.2) | 31.0 (5.5) |
| WC (cm) | 91.4 (12.8) | 90.8 (13.4) | 88.9 (13.3) | 89.0 (13.4) |
| WHR | 0.85 (0.6) | 0.86 (0.7) | 0,83 (0.7) | 0.84 (0.8) |
| FM (kg) | 19.8 (8.9) | 19.3 (9.2) | 18.6 (9.5) | 18.9 (9.7) |
| MM (kg) | 21.9 (4.7) | 23.4 (5.0) a,b | 20.9 (5.1) | 20.6 (5.1) |
| SMI (kg/m2) | 8.7 (1.8) | 9.3 (2.1) a,b | 8.5 (1.6) | 8.4 (1.5) |
Note: Results are expressed as mean (sd). BMI: body mass index; WC: waist circumference; WHR: waist to hip ratio; FM: fat mass; MM: muscle mass; SMI: skeletal muscle index. a p < 0.05 versus pre-test; b p < 0.05 versus control group (final).
Serum markers of muscle damage at different time points during the intervention programme based on resistance training in young adults with Down syndrome.
| Markers | Study Group | Control Group | ||||||
|---|---|---|---|---|---|---|---|---|
| 0-wk | 1-wk | 6-wk | 12-wk | 0-wk | 1-wk | 6-wk | 12-wk | |
| CK | 196.4 | 201.8 | 209.3 | 211.1 | 193.7 | 195.9 | 192.1 | 194.2 |
| Mb | 63.1 | 64.9 | 67.3 | 68.4 | 62.8 | 62.4 | 61.3 | 62.4 |
| LDH | 128.0 | 131.1 | 134.2 | 135.9 | 126.5 | 127.8 | 124.6 | 125.9 |
Note: Results expressed as mean (sd). wk: week; CK: creatine kinase activity expressed as U/L; Mb: myoglobin concentration expressed as ng/mL. LDH: lactate dehydrogenase activity expressed as U/L. Changes did not reach statistical significance (p > 0.05).